Kbc Group Nv Arvinas, Inc. Transaction History
Kbc Group Nv
- $32.2 Billion
- Q1 2025
A detailed history of Kbc Group Nv transactions in Arvinas, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 2,885 shares of ARVN stock, worth $22,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,885
Previous 2,885
-0.0%
Holding current value
$22,012
Previous $55,000
63.64%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARVN
# of Institutions
226Shares Held
72.2MCall Options Held
1.52MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA7.06MShares$53.9 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$51.3 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$47.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$31.3 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$25.4 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $406M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...